Duloxetine News and Research

RSS

Duloxetine is approved in the United States for the acute and maintenance treatment of major depressive disorder, the acute treatment of generalized anxiety disorder, and the management of diabetic peripheral neuropathic pain and fibromyalgia in adults aged 18 years and older. Duloxetine is not approved for use in pediatric patients.

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

As out-of-pocket costs go up for drugs for the neurologic disorders Alzheimer's disease, peripheral neuropathy and Parkinson's disease, people are less likely to take the drugs as often as their doctors prescribed, according to a study funded by the American Academy of Neurology and published in the February 19, 2020, online issue of Neurology, the medical journal of the American Academy of Neurology.

19 Feb 2020

Family doctors in rural America tackle crisis of addiction and pain

Dr. Angela Gatzke-Plamann didn’t fully grasp her community’s opioid crisis until one desperate patient called on a Friday afternoon in 2016.

10 Jan 2020

Updated guideline for management of osteoarthritis of the hand, hip and knee released

Today, the American College of Rheumatology, in partnership with the Arthritis Foundation, released the 2019 ACR/AF Guideline for the Management of Osteoarthritis of the Hand, Hip and Knee.

7 Jan 2020

Weighing risks and benefits of antidepressant medication for older adults

Depression is a common and serious problem for older adults. Some 15 to 20 percent of people aged 65 and older who live independently deal with symptoms of major depressive disorder.

12 Jun 2019

Finding better way to quantify neuropathy symptoms and treatment efficacy

Most of the roughly 15.5 million cancer survivors in the U.S. receive chemotherapy, and roughly 65 percent develop some degree of the chemotherapy-induced nerve damage known as peripheral neuropathy.

17 Apr 2018

New drug offers hope for osteoarthritis patients suffering from debilitating hand pain

Osteoarthritis is the most prevalent arthritis worldwide and is characterized by chronic pain and impaired physical function.

13 Nov 2017

Increasing the dosage of antidepressants does not carry benefits, analysis reveals

In the current issue of Psychotherapy and Psychosomatics a new analysis discloses that increasing the dosage of antidepressant drugs does not carry benefits. As many patients with unipolar depression do not respond sufficiently to initial antidepressant monotherapy, a dose increase of the current administered antidepressant (dose escalation, high-dose treatment) is frequently carried out as next treatment measure.

24 Oct 2017

Antidepressants used for chronic pain relief come with significant side effects

Chronic pain negatively impacts a person's quality of life. Often, over the counter pain medication, such as ibuprofen or aspirin, are ineffective in alleviating chronic pain. In these instances, a surprising choice is often a drug used to treat an entirely different condition - depression.

5 Sep 2017

Antidepressants and anti-seizure drugs can effectively treat diabetic nerve pain, research finds

A federal health agency has found certain antidepressants and anti-seizure drugs are among medications that effectively treat diabetic nerve pain.

25 Mar 2017

Study reports presence of structural changes in the brain during medication treatment for depression

A study led by Ravi Bansal, PhD, and Bradley S. Peterson, MD, of The Saban Research Institute of Children's Hospital Los Angeles, has found structural differences in the cerebral cortex of patients with depression and that these differences normalize with appropriate medication.

7 Mar 2017

New position statement offers recommendations for physicians on prevention of diabetic neuropathy

An estimated 60 to 70 percent of people with diabetes develop some form of diabetic neuropathy, or the chronic nerve damage diabetes causes, according to the National Institute of Diabetes and Digestive and Kidney Diseases.

31 Jan 2017

Functional MRI brain scan may help predict patient’s response to antidepressant therapy

A functional MRI brain scan may help predict which patients will respond positively to antidepressant therapy, according to a new study published in the journal Brain.

25 Jan 2017

Depression drug can alleviate joint pain in postmenopausal women treated for breast cancer

A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special plenary presentation at the San Antonio Breast Cancer Symposium.

9 Dec 2016

Duloxetine News and Research

Increase in out-of-pocket costs associated with lower adherence to neurologic medications

Family doctors in rural America tackle crisis of addiction and pain

Updated guideline for management of osteoarthritis of the hand, hip and knee released

Weighing risks and benefits of antidepressant medication for older adults

Finding better way to quantify neuropathy symptoms and treatment efficacy

New drug offers hope for osteoarthritis patients suffering from debilitating hand pain

Increasing the dosage of antidepressants does not carry benefits, analysis reveals

Antidepressants used for chronic pain relief come with significant side effects

Antidepressants and anti-seizure drugs can effectively treat diabetic nerve pain, research finds

Study reports presence of structural changes in the brain during medication treatment for depression

New position statement offers recommendations for physicians on prevention of diabetic neuropathy

Functional MRI brain scan may help predict patient’s response to antidepressant therapy

Depression drug can alleviate joint pain in postmenopausal women treated for breast cancer

Combination approach could be more effective to treat fibromyalgia pain

Most antidepressants are ineffective at treating children and teens, study shows

Nutritional supplements can enhance effectiveness of antidepressants

Botulinum toxin A injections combat neuropathic pain

Unmet medication need in neuropathic pain

AVACEN Medical launches $2M campaign in response to positive outcomes of fibromyalgia study

Breckenridge announces launch of Duloxetine Delayed-release Capsules

Irresistin: a ‘Poison Arrow’ to Defeat Antibiotic Resistance

The Role of Nutrition in Recovery from COVID-19

Improving cancer therapies by exploiting drug resistance in cancer

Latest News